The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Prinovox 250 mg + 62.5 mg spot-on solution for large dogs

250 + 62.5 mg/pipette Spot-on solution

Bayer LimitedVPA10021/075/003

Main Information

Trade NamePrinovox 250 mg + 62.5 mg spot-on solution for large dogs
Active SubstancesImidacloprid
Strength250 + 62.5 mg/pipette
Dosage FormSpot-on solution
Licence HolderBayer Limited
Licence NumberVPA10021/075/003

Group Information

ATC CodeQP54AB52 moxidectin, combinations
Therapeutic ClassEctoparasiticide


Licence Issued05/05/2017
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back